Cite
HARVARD Citation
Inagaki, N. et al. (n.d.). Linagliptin provides effective, well‐tolerated add‐on therapy to pre‐existing oral antidiabetic therapy over 1 year in Japanese patients with type 2 diabetes. Diabetes, obesity & metabolism. 15 (9), pp. 833-843. [Online].